A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP7713 in Healthy Non-Japanese Adult and Elderly Subjects and Healthy Japanese Adult Subjects
Clinical trial NCT03108755 · COMPLETED
Trial details
- NCT number
- NCT03108755
- Sponsor
- Astellas Pharma Europe B.V.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-23
- Primary completion
- 2017-08-25
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.